Literature DB >> 26508972

A Selective Mutism Arising from First Language Attrition, Successfully Treated with Paroxetine-CBT Combination Treatment.

Agostino Serra1, Paola Di Mauro1, Claudio Andaloro1, Luigi Maiolino1, Piero Pavone2, Salvatore Cocuzza1.   

Abstract

After immersion in a foreign language, speakers often have difficulty retrieving native-language words and may experience a decrease in its proficiency, this phenomenon, in the non-pathological form, is known as first language attrition. Self-perception of this low native-language proficiency and apprehension occurring when speaking is expected and, may sometimes lead these people to a state of social anxiety and, in extreme forms, can involve the withholding of speech as a primitive tool for self-protection, linking them to selective mutism. We report an unusual case of selective mutism arising from first language attrition in an Italian girl after attending a two-year "German language school", who successfully responded to a paroxetine-cognitive behavioral treatment (CBT) combination treatment.

Entities:  

Keywords:  Anxiety; Cognitive behavioral therapy; Language attrition; Paroxetine; Selective mutism

Year:  2015        PMID: 26508972      PMCID: PMC4620318          DOI: 10.4306/pi.2015.12.4.569

Source DB:  PubMed          Journal:  Psychiatry Investig        ISSN: 1738-3684            Impact factor:   2.505


  12 in total

1.  Inhibiting your native language: the role of retrieval-induced forgetting during second-language acquisition.

Authors:  Benjamin J Levy; Nathan D McVeigh; Alejandra Marful; Michael C Anderson
Journal:  Psychol Sci       Date:  2007-01

Review 2.  Selective mutism: a review and integration of the last 15 years.

Authors:  Andres G Viana; Deborah C Beidel; Brian Rabian
Journal:  Clin Psychol Rev       Date:  2008-09-30

3.  Selective mutism and the anxiety spectrum--a long-term case report.

Authors:  Gizela Turkiewicz; Lilian Lerner Castro; Marcia Morikawa; Carolina Zadrozny Gouvêa da Costa; Fernando Ramos Asbahr
Journal:  Braz J Psychiatry       Date:  2008-06       Impact factor: 2.697

4.  The development and psychometric properties of the selective mutism questionnaire.

Authors:  R Lindsey Bergman; Melody L Keller; John Piacentini; Andrea J Bergman
Journal:  J Clin Child Adolesc Psychol       Date:  2008-04

5.  Elective mutism: A case study.

Authors:  Ashok Kumar Jainer; Mohammed Quasim; M Davis
Journal:  Int J Psychiatry Clin Pract       Date:  2002       Impact factor: 1.812

Review 6.  Is selective mutism an anxiety disorder? Rethinking its DSM-IV classification.

Authors:  K D Anstendig
Journal:  J Anxiety Disord       Date:  1999 Jul-Aug

7.  Social phobia: Axis I and II correlates.

Authors:  S M Turner; D C Beidel; J W Borden; M A Stanley; R G Jacob
Journal:  J Abnorm Psychol       Date:  1991-02

8.  Psychiatric characteristics of children with selective mutism: a pilot study.

Authors:  B Black; T W Uhde
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-07       Impact factor: 8.829

9.  Elective mutism as a variant of social phobia.

Authors:  B Black; T W Uhde
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1992-11       Impact factor: 8.829

10.  Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.

Authors:  John T Walkup; Anne Marie Albano; John Piacentini; Boris Birmaher; Scott N Compton; Joel T Sherrill; Golda S Ginsburg; Moira A Rynn; James McCracken; Bruce Waslick; Satish Iyengar; John S March; Philip C Kendall
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

View more
  1 in total

Review 1.  Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies.

Authors:  M Ruggieri; A D Praticò; A Serra; L Maiolino; S Cocuzza; P Di Mauro; L Licciardello; P Milone; G Privitera; G Belfiore; M Di Pietro; F Di Raimondo; A Romano; A Chiarenza; M Muglia; A Polizzi; D G Evans
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-10       Impact factor: 2.124

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.